Canopy Growth Corporation · TSX:WEED

Canopy Growth — Investor Presentation (February 2019)

24 slides from Canopy Growth's investor presentation, February 2019

  1. Slide 1: Driving the Global Cannabis Industry

    DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Chairman, Founder & Co-CEO February 2019

  2. Slide 2: Forward-Looking Statement

    FORWARD-LOOKING STATEMENT This presentation contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “Forward-Looking State

  3. Slide 3: Company Snapshot

    COMPANY SNAPSHOT Canopy Growth (TSX:WEED) (NYSE: CGC) is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Operations in over a dozen countries Cannabis medicine research program incl. on 5 continen

  4. Slide 4: Leading the Canadian Cannabis Market

    LEADING THE CANADIAN CANNABIS MARKET

  5. Slide 5: Canadian Medical Market Leader

    CANADIAN MEDICAL MARKET LEADER • 83,000+ Patients • 56,000+ Healthcare Professional Visits1 • Certified Medical Education Program • Exclusive Pharmacy Learning Modules Accredited by Canadian Pharmacy Association and CCCEP2 • Peer Catalyst Mentor Program • Pilot Program w/ Ontario Long Term Care Asso

  6. Slide 6: Canadian Rec. Market Leadership Drives Record Revenues

    CANADIAN REC. MARKET LEADERSHIP DRIVES RECORD REVENUES Q3 FY19 Net Revenue ($M) $90 $83.0 $75 3 $59.0 $60 30%+ $45 $30 $16.5 Share of SKUs $15 $0 Available Nationwide1 Medical Rec Total Q3 FY19 Shipments (Kg & Kg Equiv.) 12,000 10,102 3 8,267 8,000 3 70,000+ kg/yr 4,000 1,815 Minimum Supply Commitme

  7. Slide 7: Engaging Retail – Build Brand, Build Demand

    ENGAGING RETAIL – BUILD BRAND, BUILD DEMAND Brick & Mortar1 Online Government Private Hybrid 8 In Process 5 15 In Process Technology-enabled, Nationwide sales force 1 Store count includes Tweed and Tokyo Smoke locations 7

  8. Slide 8: Recreational Market Leader – Physical Retail Builds Brands

    RECREATIONAL MARKET LEADER – PHYSICAL RETAIL BUILDS BRANDS 8

  9. Slide 9: Recreational Market Leader – Physical Retail Builds Brands

    RECREATIONAL MARKET LEADER – PHYSICAL RETAIL BUILDS BRANDS 9

  10. Slide 10: Cannabis: A Potentially Disruptive Ingredient

    CANNABIS: A POTENTIALLY DISRUPTIVE INGREDIENT Potential Global Market Disruption - $500B+ Target Markets Include: Athletic Drinks1 $40B Pain Relief5 $90B Animal Health2 $50B Sleep6 $100B Anxiety3 $18B Health & Wellness7 $1T+ PTSD4 $10B Beverage Alcohol8 $1T+ 1. USD $30B in 2017, Source - Industry Ar

  11. Slide 11: Cannabis: A Potentially Disruptive Ingredient

    CANNABIS: A POTENTIALLY DISTRUPTIVE INGREDIENT NO ALCOHOL NO CALORIES NO HANGOVER HAPPY LIVER 11

  12. Slide 12: Digging Our Economic Moat

    DIGGING OUR ECONOMIC MOAT gh Fp, 6 71 Spectrum Cannabis:

  13. Slide 13: Developing Cannabis-Based Beverages

    DEVELOPING CANNABIS-BASED BEVERAGES – 2+ YEAR R&D PROGRAM GOALS OUTCOME • Calorie free Formulation developed using • Transparent all natural ingredients with a • Fast onset unique process order that • Long shelf life creates a stable, cannabinoid • Compatible with a variety of containing, optically

  14. Slide 14: Canopy Health Innovations

    CANOPY HEALTH INNOVATIONS RESEARCH PROGRAM1 PATENT APPLICATIONS 43 FILED WITH USPTO2 HUMAN HEALTH CLINICAL 15 TRIALS INCLUDING PHASE IIB SLEEP TRIALS3 ANIMAL HEALTH CLINICAL 4 TRIALS INCLUDING COMPANION ANIMAL ANXIETY 1 Includes trials underway or planned 2 Across CHI, Canopy Animal Health and Canop

  15. Slide 15: Canopy Health Innovations

    CANOPY HEALTH INNOVATIONS Conduct research that validates the efficacy and safety of consumer products Safety 15

  16. Slide 16: Growing IP Portfolio

    GROWING IP PORTFOLIO XXXX Image of gas lamp type 32 PATENTS, 140+ PATENT APPLICATIONS FILED TO light bulb (bad example DATE, MANY MORE UNDER DEVELOPMENT below) • Cannabis-based beverage production • Cannabis-based medical treatments • Device & delivery technologies • Large-scale cannabis processing

  17. Slide 17: Canopy Innovation Driving the World

    CANOPY INNOVATION DRIVING THE WORLD

  18. Slide 18: The Legalization of Cannabis Is Spreading Globally

    THE LEGALIZATION OF CANNABIS IS SPREADING GLOBALLY Medical & Adult-Use Legalized Medical Use Legalized In the Process of Legalizing Medical Use / Exploring Legalization Industrial Hemp legalized – Path for Canopy Growth to enter US market 18

  19. Slide 19: Driving Global Growth

    DRIVING GLOBAL GROWT *& Cutwation/License Application’ Facilty Under Development Be opore msn GMP caP-corttied Facility ¢ wv 2) Spectrum Cannabis 19

  20. Slide 20: $5 Billion Investment to Accelerate Global Growth Plans

    INVESTMENT TO ACCELERATE GLOBAL GROWTH PLANS $5 BILLION USE OF PROCEEDS: • Expansion in Europe & South America • Entry Into United States • R&D Support • Mergers & Acquisitions 20

  21. Slide 21: Hemp Farming Act of 2018

    HEMP FARMING ACT OF 2018 CANOPY GROWTH TO INVEST $100M - $150M IN NEW YORK STATE HEMP INDUSTRIAL PARK EXTRACTION & PRODUCT MANUFACTURING 21

  22. Slide 22: Management Team

    MANAGEMENT TEAM Bruce Linton Mark Zekulin Tim Saunders Dr. Mark Ware Chairman & Co-CEO President & Co-CEO EVP & Chief Financial Officer Chief Medical Officer 22

  23. Slide 23: Management Team

    MANAGEMENT TEAM Phil Shaer Amanda Daley Rade Kovacevic Dave Bigioni Chief Legal Officer VP, Medical Sales & Education Executive Vice President Chief Commercial Officer 23

  24. Slide 24: Bruce Linton

    BRUCE LINTON Founder, Chairman & Co-CEO bruce@canopygrowth.com 24

Canopy Growth — Investor Presentation (February 2019) on 6ix